These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1. Zhang R; Rong X; Pan W; Peng T Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624 [TBL] [Abstract][Full Text] [Related]
7. Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic. Ceyhan M; Yildirim I; Ferraris O; Bouscambert-Duchamp M; Frobert E; Uyar N; Tezer H; Oner AF; Buzgan T; Torunoglu MA; Ozkan B; Yilmaz R; Kurtoglu MG; Laleli Y; Badur S; Lina B Epidemiol Infect; 2010 Sep; 138(9):1274-80. PubMed ID: 20092669 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of antibodies to avian influenza virus A (H5N1) among residents of villages with human cases, Thailand, 2005. Dejpichai R; Laosiritaworn Y; Phuthavathana P; Uyeki TM; O'Reilly M; Yampikulsakul N; Phurahong S; Poorak P; Prasertsopon J; Kularb R; Nateerom K; Sawanpanyalert N; Jiraphongsa C Emerg Infect Dis; 2009 May; 15(5):756-60. PubMed ID: 19402962 [TBL] [Abstract][Full Text] [Related]
9. Homosubtypic and heterosubtypic antibodies against highly pathogenic avian influenza H5N1 recombinant proteins in H5N1 survivors and non-H5N1 subjects. Noisumdaeng P; Pooruk P; Prasertsopon J; Assanasen S; Kitphati R; Auewarakul P; Puthavathana P Virology; 2014 Apr; 454-455():254-62. PubMed ID: 24725952 [TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. Vong S; Ly S; Van Kerkhove MD; Achenbach J; Holl D; Buchy P; Sorn S; Seng H; Uyeki TM; Sok T; Katz JM J Infect Dis; 2009 Jun; 199(12):1744-52. PubMed ID: 19416078 [TBL] [Abstract][Full Text] [Related]
11. Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia. Shimizu K; Wulandari L; Poetranto ED; Setyoningrum RA; Yudhawati R; Sholikhah A; Nastri AM; Poetranto AL; Candra AY; Puruhito EF; Takahara Y; Yamagishi Y; Yamaoka M; Hotta H; Ustumi T; Lusida MI; Soetjipto ; Shimizu YK; Soegiarto G; Mori Y J Infect Dis; 2016 Dec; 214(12):1929-1936. PubMed ID: 27923953 [TBL] [Abstract][Full Text] [Related]
12. Anti N1 cross-protecting antibodies against H5N1 detected in H1N1 infected people. Frobert E; Bouscambert-Duchamp M; Escuret V; Mundweiler S; Barthélémy M; Morfin F; Valette M; Gerdil C; Lina B; Ferraris O Curr Microbiol; 2010 Jul; 61(1):25-8. PubMed ID: 20033691 [TBL] [Abstract][Full Text] [Related]
13. Sparse serological evidence of H5N1 avian influenza virus infections in domestic cats, northeastern China. Sun L; Zhou P; He S; Luo Y; Jia K; Fu C; Sun Y; He H; Tu L; Ning Z; Yuan Z; Wang H; Li S; Yuan L Microb Pathog; 2015 May; 82():27-30. PubMed ID: 25752867 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Apisarnthanarak A; Erb S; Stephenson I; Katz JM; Chittaganpitch M; Sangkitporn S; Kitphati R; Thawatsupha P; Waicharoen S; Pinitchai U; Apisarnthanarak P; Fraser VJ; Mundy LM Clin Infect Dis; 2005 Jan; 40(2):e16-8. PubMed ID: 15655735 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection. Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756 [TBL] [Abstract][Full Text] [Related]
16. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. Katz JM; Lim W; Bridges CB; Rowe T; Hu-Primmer J; Lu X; Abernathy RA; Clarke M; Conn L; Kwong H; Lee M; Au G; Ho YY; Mak KH; Cox NJ; Fukuda K J Infect Dis; 1999 Dec; 180(6):1763-70. PubMed ID: 10558929 [TBL] [Abstract][Full Text] [Related]
17. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans. Tang JW; Ngai KL; Chan PK J Med Virol; 2008 Nov; 80(11):1992-6. PubMed ID: 18814271 [TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits. Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575 [TBL] [Abstract][Full Text] [Related]
19. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Rowe T; Abernathy RA; Hu-Primmer J; Thompson WW; Lu X; Lim W; Fukuda K; Cox NJ; Katz JM J Clin Microbiol; 1999 Apr; 37(4):937-43. PubMed ID: 10074505 [TBL] [Abstract][Full Text] [Related]
20. Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Kitphati R; Pooruk P; Lerdsamran H; Poosuwan S; Louisirirotchanakul S; Auewarakul P; Chokphaibulkit K; Noisumdaeng P; Sawanpanyalert P; Puthavathana P Clin Vaccine Immunol; 2009 Jul; 16(7):978-81. PubMed ID: 19458206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]